Skip to content

Treasury Stock at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$19.41B+19.7%
Opko Health logo
Opko HealthOPK
$1.79M0.0%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$10.98M0.0%
Azenta logo
AzentaAZTA
$200.96M
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$25.26M
Arrowhead Research logo
Arrowhead ResearchARWR
$53.19M

Other financials

Income statement

See full
Revenue$293.0K-84.8%
Operating income-$40.8M+1.9%
Net income-$46.3M-15.8%
EPS (diluted)-$0.57-11.8%

Balance sheet

See full
Cash & equivalents$71.5M+7.5%
Total debt$62.7M-22.5%
Total equity-$58.1M-276%
Total assets$244.7M+9.2%

Cash flow

See full
Operating cash flow$17.8M+148%
CapEx$2.0M+17.4%
Free cash flow$15.8M+141%

Valuation

See full
Market cap$1.07B+111%
Enterprise value$1.07B+103%
P/S13.5×-1.3×

Profitability

See full
Operating margin-597.9%-207pp
Net margin-615.3%
FCF margin-441.5%-126pp

Returns & leverage

See full
Return on equity-379.5%
Debt / equity27.2×+26.1×
Current ratio0.5×-1.0×

Where this comes from

Reported directly by MeiraGTx Holdings plc in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonValue.

The official record: MeiraGTx Holdings plc’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MeiraGTx Holdings plc's treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MeiraGTx Holdings plc's treasury stock?
MeiraGTx Holdings plc (MGTX) reported treasury stock of $18.19M in Q1 2026.
What does treasury stock mean?
Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.